Drug intelligence / Profile preview

senna + docusate sodium + bisacodyl + magnesium hydroxide + polyethylene glycol 3350

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

This is a combination therapy consisting of five active ingredients commonly used as laxatives for the treatment of constipation and bowel preparation. The components are: - **Senna**: A stimulant laxative that increases peristalsis by direct action on the intestinal mucosa or nerve plexus. - **Docusate sodium**: A stool softener that lowers the surface tension of stool, allowing water and fats to penetrate and soften it. - **Bisacodyl**: Another stimulant laxative that acts directly on the colon to stimulate bowel movements. - **Magnesium hydroxide**: An osmotic laxative that draws water into the intestines, increasing stool bulk and triggering peristalsis. - **Polyethylene glycol 3350 (Miralax)**: An osmotic agent that retains water in the stool, resulting in softer stools and increased frequency of bowel movements[1][2][5][6][8].

Brand names
Miralax
Other names
senna + docusate sodium + bisacodyl + magnesium hydroxide + Miralax-Shriners Hospitals for Children-opioid-induced constipationShriners Hospitals for Children Bowel ProtocolStandard institutional bowel protocol
02

Targets

ESR1 (ERα)AQP3 (Aquaporin-3 channel protein)

Beyond the preview

Go deeper on senna + docusate sodium + bisacodyl + magnesium hydroxide + polyethylene glycol 3350.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on senna + docusate sodium + bisacodyl + magnesium hydroxide + polyethylene glycol 3350.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call